Survey of pulmonary tuberculosis in south and west Wales (1976-8).

Abstract

In routine clinical practice 20% of patients with pulmonary tuberculosis were treated with the regimen recommended by the British Thoracic Association after the British trial of short-course chemotherapy. Despite the use of several regimens that could be considered inadequate, no patient from the survey within south and west Wales appears to have relapsed yet. Deaths from pulmonary tuberculosis continue at the same rate as 10 years ago. Patient default remains a difficult problem even with modern, less toxic, short-course regimens.

Chemotherapy and management of tuberculosis in the United Kingdom: recommendations of the Joint Tuberculosis Committee of the British Thoracic Society.

“…Such treatment must be closely monitored, as full compliance is essential to prevent the emergence of further drug resistance. 4 After treatment Relapse is uncommon in the United Kingdom with the recommended regimen (0-3% of 4i07 Ormerod cases) if there is good compliance with treatment. 35 If compliance has been good and there are no residual clinical problems no follow up is required, but the patient should be advised to return if symptoms recur.…”

Short-Course Chemotherapy for Tuberculosis

“…95 He had to deal with the fundamental conservatism of physicians. It's a great pity 93 Monie et al (1982). 94 Tuberculosis Society of Scotland (1960).…”